Swedish PRrecision medicine Initiative for Novel Treatment and Research

The SPRINTR Swedish PRrecision medicine Initiative for Novel Treatment and Research is building a research infrastructure with the goal of driving the development of biomarker-driven precision medicine in cancer.  

Men who are being investigated for prostate cancer are offered to participate in the study as a natural part of the clinical routine. By simultaneously collecting data from molecular profiling, imaging, registries and other information sources, a multimodal platform cohort is built that enables high-quality cancer research with the goal of improving both quality of life and survival.

SPRINTR is being developed from the beginning as a scalable model that can be expanded to more cancer groups nationally in collaboration with existing infrastructure and national initiatives. 

The infrastructure consists of three interacting components that together form a unified whole:

• A central core for research person inclusion and smart IT solutions that connect national research and healthcare environments.
• A joint agreement package and governing documents, which make it possible to handle personal data securely and efficiently between regions, higher education institutions and external actors.
• Digital tools for contact with research subjects and study administration, which improve matching to clinical trials and make it easier to include participants correctly and quickly.

SPRINTR is first developed for prostate cancer, but is originally built as a flexible and scalable model – ready to be used for all cancers nationally.

Read more about the research project